Pulse Biosciences, Inc. PLSE Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | —— | —— | —— | ||
| $30.89M— | $32.03M— | $34.3M— | $31.47M— | —— | ||
| -$74.57M-23.8% | -$72.78M-35.8% | -$74.73M-62.0% | -$68.03M-54.5% | -$60.24M-41.6% | ||
| $666K+0.2% | $665K-0.2% | $665K-0.2% | $666K+0.2% | $665K0.0% | ||
| $381K-13.0% | $410K-9.5% | $438K-6.8% | $438K-6.8% | $438K-6.8% | ||
| —— | —— | $1.31M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | $1.72M— | ||
| $176K+487% | $136K— | $57K— | $51K— | $30K— | ||
| $760K— | $912K— | —— | —— | —— | ||
| $4.56M-96.4% | $17.15M-84.5% | $64.98M+3.1% | $124.91M+3,734% | $124.91M+629% | ||
| -$323K-95.8% | -$335K-168% | -$283K-146% | -$259K-159% | -$165K-89.7% | ||
| -$55.2M-37.7% | -$54.12M-48.9% | -$48.51M-42.8% | -$44.5M-25.5% | -$40.08M-10.6% | ||
| -$70K— | -$52K— | -$57K— | -$39K— | —— | ||
| —— | —— | —— | —— | $69K— | ||
| $57K— | $0— | $59K— | —— | —— | ||
| $303K+83.6% | $315K+152% | $263K+129% | $239K+139% | $165K+89.7% | ||
| $3.78M+204% | $2.49M+186% | $2.47M+89.9% | $1.24M+9.3% | $1.24M+5.3% | ||
| —— | —— | —— | —— | —— | ||
| $17.69M+1.0% | $21.46M+57.9% | $23.28M+130% | $20.65M+131% | $17.51M+118% | ||
| -$77M-23.0% | -$75.86M-37.6% | -$77.84M-64.3% | -$71.13M-58.1% | -$62.58M-43.9% | ||
| -$78.05M-22.5% | -$76.94M-36.8% | -$78.95M-62.7% | -$72.24M-56.6% | -$63.69M-42.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pulse Biosciences, Inc.'s profit margins?
- Gross margin is -4067.5% and operating margin is -10392.1%, with a -9929.0% net margin.
- Where does Pulse Biosciences, Inc.'s income statement data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.